Latest news with #CronosGroup
Washington Post
08-05-2025
- Business
- Washington Post
Cronos: Q1 Earnings Snapshot
STAYNER, Ontario — STAYNER, Ontario — Cronos Group Inc. (CRON) on Thursday reported profit of $6.1 million in its first quarter. The Stayner, Ontario-based company said it had profit of 2 cents per share. The cannabis company posted revenue of $32.3 million in the period. _____ This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on CRON at
Yahoo
28-04-2025
- Business
- Yahoo
Where Will Altria Stock Be in 3 Years?
Altria (NYSE: MO) stock has long been a favorite among income investors and it's clear why. The company has raised its dividend 59 times in the last 55 years, making it a Dividend King, and it remains a dividend powerhouse based on its yield as well, as it currently offers a dividend yield of 7%. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » These days, Altria may be getting some extra attention from investors as tobacco has a well-established track record as a recession-proof product as smokers and other tobacco consumers buy the product regardless of economic conditions. That may make Altria especially attractive during the high volatility around the trade war and a weakening economy. If you're considering buying shares of Altria or currently own the stock, you'll likely want to know where the company is headed. Let's explore that subject to learn where the domestic Marlboro maker will be in three years. Altria was one of the best stocks to own over much of its history, but it's struggled over the last decade due to the decline of smoking and some strategic blunders, including investing more than $12 billion in Juul shortly before regulators cracked down on the flavored vape maker, and its investment in cannabis company Cronos Group was also a bust. After selling the rights to market Iqos in the U.S., a heat-not-burn tobacco device, back to Philip Morris International, its bet on Njoy for growth in smoke-free products as Njoy benefits from having the only pod-based e-vapor product that has received marketing authorization from the FDA. Njoy is also the only FDA-authorized menthol e-vapor product on the market. That approval is key as it will ensure that the company won't face the same problems with Njoy that it did with Juul. Altria's next-gen, smoke-free portfolio also includes on!, an oral nicotine pouch that competes with Philip Morris's Zyn, and it's working on bring a new heated tobacco product to market called Ploom under a majority-owned joint venture with JT Group called Horizon Innovations. Of those products, Njoy, which Altria acquired in 2023 for $2.75 billion, seems to be the most promising. In the fourth quarter, Njoy consumables rose 15.3% to 12.8 million, and device shipments increased 22.2% to 1.1 million. Its retail market share of consumables also nearly doubled to 6.4%, a promising sign. Despite Njoy's success, cigarettes still make up the vast majority of the company's business and are likely to do so for the foreseeable future. Volume sales of its cigarettes continue to fall rapidly, declining from 76.4 million in 2023 to 68.6 million in 2024, and smokeable products made up 88% of its revenue in 2024. Despite the volume decline in cigarettes, Altria managed to grow profits with the help of price hikes. Assessing Altria's position in three years is relatively easy as the company has spelled out a set of goals for 2028. The question then becomes if the company can hit those goals. Altria is aiming to deliver mid-single digits adjusted earnings per share compound annual growth rate (CAGR) off $4.84 in 2022. In 2024, adjusted EPS rose 3.4% to $5.12, giving it a CAGR of 2.9% over the last two years. The company expects to raise its dividend by mid-single digits annually, following a 4.1% dividend increase in 2024. It's also targeting a debt-to-earnings before interest, taxes, depreciation, and amortization (EBITDA) ratio of 2. Currently, that figure is 2.1. Altria expects to generate an adjusted operating margin of at least 60% in every year through 2028. Thus far, Altria has struggled to achieve the growth rates necessary to accomplish those goals, and it also stepped back from earlier goals of having Njoy be accretive to cash flow in 2025 and EPS in 2026. Altria might not hit all of its 2028 goals, but it doesn't have to for the stock to be successful. Shares currently trades at a price-to-earnings ratio of just 12 and offers a 7% dividend yield with a proven commitment to raising it. Altria also finally seems to be on the right track with smoke-free products with Njoy after wasting several years with Juul. In the current bearish economic environment, Altria looks like it has a good chance of outperforming the S&P 500, especially on a total return basis. The tobacco company has the benefit of competing in the consumer staples sector, selling a product that consumers buy regardless of the economy, and its dividend will reward investors regardless of the volatility of the stock market. Overall, despite the decline in cigarette consumption, Altria seems likely to be in a better position three years from now than it is today. Before you buy stock in Altria Group, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Altria Group wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $594,046!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $680,390!* Now, it's worth noting Stock Advisor's total average return is 872% — a market-crushing outperformance compared to 160% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of April 21, 2025 Jeremy Bowman has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Cronos Group. The Motley Fool recommends Philip Morris International. The Motley Fool has a disclosure policy. Where Will Altria Stock Be in 3 Years? was originally published by The Motley Fool Sign in to access your portfolio
Yahoo
03-04-2025
- Business
- Yahoo
TSX April 2025 Spotlight: Promising Penny Stocks To Consider
As the Canadian market navigates through trade uncertainty and inflation concerns, investors are keenly observing how newly announced tariffs might impact economic growth. Amidst this backdrop, penny stocks—often representing smaller or newer companies—continue to capture attention for their potential value and growth opportunities. Despite being a somewhat outdated term, these stocks can offer affordability paired with financial strength, making them an intriguing option for those looking to explore promising investment avenues in today's market landscape. Name Share Price Market Cap Financial Health Rating Westbridge Renewable Energy (TSXV:WEB) CA$0.71 CA$68.78M ★★★★★★ Haivision Systems (TSX:HAI) CA$4.32 CA$121.88M ★★★★★☆ NTG Clarity Networks (TSXV:NCI) CA$1.82 CA$78.83M ★★★★★☆ Intermap Technologies (TSX:IMP) CA$1.87 CA$109.04M ★★★★☆☆ Orezone Gold (TSX:ORE) CA$0.92 CA$484.66M ★★★★★☆ Dynacor Group (TSX:DNG) CA$4.70 CA$201.34M ★★★★★★ PetroTal (TSX:TAL) CA$0.69 CA$613.7M ★★★★★☆ McCoy Global (TSX:MCB) CA$3.12 CA$88.33M ★★★★★★ Findev (TSXV:FDI) CA$0.48 CA$13.75M ★★★★★★ BluMetric Environmental (TSXV:BLM) CA$1.17 CA$42.83M ★★★★★★ Click here to see the full list of 923 stocks from our TSX Penny Stocks screener. Here's a peek at a few of the choices from the screener. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Cronos Group Inc. is a cannabinoid company involved in the cultivation, production, distribution, and marketing of cannabis products across Canada, Israel, and internationally with a market cap of CA$979.28 million. Operations: The company's revenue primarily comes from the cultivation, manufacture, and marketing of cannabis and cannabis-derived products, totaling $117.62 million. Market Cap: CA$979.28M Cronos Group Inc., with a market cap of CA$979.28 million, has recently turned profitable, reporting a net income of US$41.08 million for 2024 compared to a significant loss the previous year. The company's revenue grew to US$117.62 million, driven by its cannabis operations across multiple regions. Despite low return on equity and past earnings volatility due to one-off losses, Cronos remains debt-free with strong asset coverage over liabilities. The recent appointment of Anna Shlimak as CFO could enhance strategic initiatives aimed at long-term growth and operational efficiency within the cannabis sector. Take a closer look at Cronos Group's potential here in our financial health report. Gain insights into Cronos Group's outlook and expected performance with our report on the company's earnings estimates. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Erdene Resource Development Corporation is engaged in the exploration and development of precious and base metal deposits in Mongolia, with a market cap of CA$290.21 million. Operations: Erdene Resource Development Corporation does not report distinct revenue segments. Market Cap: CA$290.21M Erdene Resource Development Corporation, with a market cap of CA$290.21 million, is pre-revenue and debt-free, focusing on precious and base metal exploration in Mongolia. The company has a seasoned management team with an average tenure of 14.2 years and an experienced board averaging 8.8 years. Despite its unprofitability and negative return on equity (-13.25%), Erdene has reduced losses by 12.8% annually over five years and maintains sufficient cash runway for over a year based on current free cash flow levels. Recent earnings reported a net loss of CA$8.25 million for 2024, contrasting with the previous year's net income. Navigate through the intricacies of Erdene Resource Development with our comprehensive balance sheet health report here. Learn about Erdene Resource Development's historical performance here. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Inventus Mining Corp. focuses on the acquisition, exploration, and development of mineral properties in Canada with a market cap of CA$16.47 million. Operations: Inventus Mining Corp. does not report any revenue segments. Market Cap: CA$16.47M Inventus Mining Corp., with a market cap of CA$16.47 million, is pre-revenue and debt-free, focusing on mineral exploration in Canada. The company has an experienced management team with an average tenure of 8.4 years and a seasoned board averaging 4.3 years. Recent drilling at the Pardo Gold Project confirmed continuity of shallow gold mineralization, indicating potential for low-cost surface mining near Sudbury, Ontario. Inventus plans further drilling to expand this resource before estimating its size formally. Despite having short-term liabilities slightly exceeding assets, the firm maintains a cash runway exceeding one year based on current free cash flow estimates. Click here and access our complete financial health analysis report to understand the dynamics of Inventus Mining. Assess Inventus Mining's previous results with our detailed historical performance reports. Click here to access our complete index of 923 TSX Penny Stocks. Ready To Venture Into Other Investment Styles? These 12 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include TSX:CRON TSX:ERD and TSXV:IVS. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
03-03-2025
- Business
- Yahoo
TSX Penny Stocks Spotlight: Cronos Group And 2 Other Noteworthy Picks
The Canadian market has experienced a period of sideways consolidation over the past three months, which may act as a corrective force amidst ongoing policy uncertainty and trade worries. In such conditions, investors often seek diversification to balance their portfolios, and penny stocks can offer intriguing opportunities due to their affordability and potential for growth. Although the term "penny stocks" might seem outdated, these smaller or newer companies can still provide value and growth prospects when backed by strong financials. Name Share Price Market Cap Financial Health Rating Alvopetro Energy (TSXV:ALV) CA$4.72 CA$172.56M ★★★★★★ Findev (TSXV:FDI) CA$0.50 CA$14.32M ★★★★★★ Mandalay Resources (TSX:MND) CA$4.79 CA$449.82M ★★★★★★ PetroTal (TSX:TAL) CA$0.69 CA$632.31M ★★★★★★ BluMetric Environmental (TSXV:BLM) CA$0.97 CA$35.81M ★★★★★★ New Gold (TSX:NGD) CA$3.93 CA$3.11B ★★★★★☆ NamSys (TSXV:CTZ) CA$1.15 CA$30.89M ★★★★★★ Amerigo Resources (TSX:ARG) CA$1.81 CA$298.08M ★★★★★☆ Foraco International (TSX:FAR) CA$2.03 CA$200.35M ★★★★★☆ Orezone Gold (TSX:ORE) CA$0.82 CA$379.19M ★★★★★☆ Click here to see the full list of 931 stocks from our TSX Penny Stocks screener. Underneath we present a selection of stocks filtered out by our screen. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Cronos Group Inc. is a cannabinoid company involved in the cultivation, production, and marketing of cannabis products in Canada, Israel, and Germany with a market cap of CA$1.13 billion. Operations: The company generates revenue of $117.62 million from its operations in cultivating, manufacturing, and marketing cannabis and cannabis-derived products. Market Cap: CA$1.13B Cronos Group has shown financial improvement, becoming profitable with a net income of US$41.08 million for 2024, reversing a previous year's loss. The company reported full-year revenue of US$117.62 million, indicating growth from the prior year. Despite earnings forecasted to decline by an average of 16.8% annually over the next three years, revenue is expected to grow by 10.53% per year. Cronos remains debt-free and its short-term assets significantly exceed liabilities, although its Return on Equity is low at 3.6%. The management team is experienced; however, the board lacks seasoned members. Unlock comprehensive insights into our analysis of Cronos Group stock in this financial health report. Examine Cronos Group's earnings growth report to understand how analysts expect it to perform. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Discovery Silver Corp. is a mineral exploration company focused on the exploration and development of polymetallic mineral deposits, with a market capitalization of CA$632.73 million. Operations: Discovery Silver Corp. has not reported any revenue segments. Market Cap: CA$632.73M Discovery Silver Corp., a pre-revenue entity with a market cap of CA$632.73 million, maintains financial stability with no debt and short-term assets of CA$37.1 million exceeding liabilities. Despite being unprofitable and experiencing increased losses over the past five years, the company has secured a cash runway for over a year at current free cash flow levels. Recent developments include raising CAD 225 million through equity offerings to support its acquisition strategy, notably the Porcupine Complex in Ontario. Management is experienced with an average tenure of 2.2 years, while its board averages 6.7 years in tenure. Click here to discover the nuances of Discovery Silver with our detailed analytical financial health report. Review our growth performance report to gain insights into Discovery Silver's future. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Royal Road Minerals Limited is involved in the exploration and development of mineral properties across Saudi Arabia, Morocco, Colombia, and Nicaragua with a market cap of CA$30.56 million. Operations: Royal Road Minerals Limited has not reported any specific revenue segments. Market Cap: CA$30.56M Royal Road Minerals Limited, with a market cap of CA$30.56 million, is pre-revenue and currently unprofitable. The company maintains financial stability with short-term assets of CA$10.5 million surpassing both its short-term liabilities of CA$208.7K and long-term liabilities of CA$11.6K, while being debt-free enhances its financial resilience. Its cash runway extends over three years based on current free cash flow levels, providing a buffer for ongoing operations despite historical losses increasing at 25.6% per year over the past five years. Management and board members are experienced, averaging tenures of 4.3 and 3.3 years respectively. Dive into the specifics of Royal Road Minerals here with our thorough balance sheet health report. Gain insights into Royal Road Minerals' past trends and performance with our report on the company's historical track record. Click through to start exploring the rest of the 928 TSX Penny Stocks now. Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive. Simply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Jump on the AI train with fast growing tech companies forging a new era of innovation. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include TSX:CRON TSX:DSV and TSXV:RYR. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
Yahoo
03-03-2025
- Business
- Yahoo
TSX Penny Stocks Spotlight: Cronos Group And 2 Other Noteworthy Picks
The Canadian market has experienced a period of sideways consolidation over the past three months, which may act as a corrective force amidst ongoing policy uncertainty and trade worries. In such conditions, investors often seek diversification to balance their portfolios, and penny stocks can offer intriguing opportunities due to their affordability and potential for growth. Although the term "penny stocks" might seem outdated, these smaller or newer companies can still provide value and growth prospects when backed by strong financials. Name Share Price Market Cap Financial Health Rating Alvopetro Energy (TSXV:ALV) CA$4.72 CA$172.56M ★★★★★★ Findev (TSXV:FDI) CA$0.50 CA$14.32M ★★★★★★ Mandalay Resources (TSX:MND) CA$4.79 CA$449.82M ★★★★★★ PetroTal (TSX:TAL) CA$0.69 CA$632.31M ★★★★★★ BluMetric Environmental (TSXV:BLM) CA$0.97 CA$35.81M ★★★★★★ New Gold (TSX:NGD) CA$3.93 CA$3.11B ★★★★★☆ NamSys (TSXV:CTZ) CA$1.15 CA$30.89M ★★★★★★ Amerigo Resources (TSX:ARG) CA$1.81 CA$298.08M ★★★★★☆ Foraco International (TSX:FAR) CA$2.03 CA$200.35M ★★★★★☆ Orezone Gold (TSX:ORE) CA$0.82 CA$379.19M ★★★★★☆ Click here to see the full list of 931 stocks from our TSX Penny Stocks screener. Underneath we present a selection of stocks filtered out by our screen. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Cronos Group Inc. is a cannabinoid company involved in the cultivation, production, and marketing of cannabis products in Canada, Israel, and Germany with a market cap of CA$1.13 billion. Operations: The company generates revenue of $117.62 million from its operations in cultivating, manufacturing, and marketing cannabis and cannabis-derived products. Market Cap: CA$1.13B Cronos Group has shown financial improvement, becoming profitable with a net income of US$41.08 million for 2024, reversing a previous year's loss. The company reported full-year revenue of US$117.62 million, indicating growth from the prior year. Despite earnings forecasted to decline by an average of 16.8% annually over the next three years, revenue is expected to grow by 10.53% per year. Cronos remains debt-free and its short-term assets significantly exceed liabilities, although its Return on Equity is low at 3.6%. The management team is experienced; however, the board lacks seasoned members. Unlock comprehensive insights into our analysis of Cronos Group stock in this financial health report. Examine Cronos Group's earnings growth report to understand how analysts expect it to perform. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Discovery Silver Corp. is a mineral exploration company focused on the exploration and development of polymetallic mineral deposits, with a market capitalization of CA$632.73 million. Operations: Discovery Silver Corp. has not reported any revenue segments. Market Cap: CA$632.73M Discovery Silver Corp., a pre-revenue entity with a market cap of CA$632.73 million, maintains financial stability with no debt and short-term assets of CA$37.1 million exceeding liabilities. Despite being unprofitable and experiencing increased losses over the past five years, the company has secured a cash runway for over a year at current free cash flow levels. Recent developments include raising CAD 225 million through equity offerings to support its acquisition strategy, notably the Porcupine Complex in Ontario. Management is experienced with an average tenure of 2.2 years, while its board averages 6.7 years in tenure. Click here to discover the nuances of Discovery Silver with our detailed analytical financial health report. Review our growth performance report to gain insights into Discovery Silver's future. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Royal Road Minerals Limited is involved in the exploration and development of mineral properties across Saudi Arabia, Morocco, Colombia, and Nicaragua with a market cap of CA$30.56 million. Operations: Royal Road Minerals Limited has not reported any specific revenue segments. Market Cap: CA$30.56M Royal Road Minerals Limited, with a market cap of CA$30.56 million, is pre-revenue and currently unprofitable. The company maintains financial stability with short-term assets of CA$10.5 million surpassing both its short-term liabilities of CA$208.7K and long-term liabilities of CA$11.6K, while being debt-free enhances its financial resilience. Its cash runway extends over three years based on current free cash flow levels, providing a buffer for ongoing operations despite historical losses increasing at 25.6% per year over the past five years. Management and board members are experienced, averaging tenures of 4.3 and 3.3 years respectively. Dive into the specifics of Royal Road Minerals here with our thorough balance sheet health report. Gain insights into Royal Road Minerals' past trends and performance with our report on the company's historical track record. Click through to start exploring the rest of the 928 TSX Penny Stocks now. Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive. Simply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Jump on the AI train with fast growing tech companies forging a new era of innovation. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include TSX:CRON TSX:DSV and TSXV:RYR. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
